Molecular Mind's MMDesign hits 18 of 19 antibody design projects in lab tests
AIMolecular Mind says its MMDesign platform produced experimentally confirmed binders in 18 of 19 de novo design projects, a 94.7% project success rate. The company reports 139 of 453 tested candidates bound, a 30.7% candidate hit rate, including all six GPCR targets tested, with best affinities in the nanomolar range.
Source details
QbitAI · 思邈 · qbitai.comPublished · added here
Original title: 19个项目18个成功，6个GPCR靶点全获命中！国产AI制药再破技术天花板